Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPB2 pseudogene 1 (SNRPB2P1) is officially classified as a pseudogene based on major gene databases[5]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode proteins and have no established role in cellular pathways. Accordingly, SNRPB2P1 does not participate in known biological processes, is not considered a molecular target in pharmacology or drug discovery, and lacks disease associations, actionable biomarkers, therapeutic drugs, or established safety concerns[5]. This entity should not be confused with SNRPB2 (Small Nuclear Ribonucleoprotein Polypeptide B2), which is a protein-coding gene with roles in RNA processing and cancer progression[1][2][3][4]. Key clarification: There is *no evidence* that SNRPB2P1 encodes a functional protein or acts as a receptor, enzyme, transporter, transcription factor, or other canonical drug target[5]. If a functional or disease-related SNRPB2 target is desired, information should reference **SNRPB2**, not the SNRPB2 pseudogene 1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNRPB2 pseudogene 1 (SNRPB2P1).